PMHNP Confidence
Disclosing a Medication Error: PMHNP Confidence Script 2026
A new PMHNP just made a med error — what to say in 60 minutes. The 2026 6-beat disclosure script, apology-law map by state, and a defensible chart note.
Read More →TL;DR
- A 2018 JAMA Psychiatry trial found that patients who left the ED with a Stanley-Brown safety plan and follow-up calls had 45 percent fewer suicidal behaviors over 6 months and were more than twice as likely to attend outpatient follow-up.
- The Columbia-Suicide Severity Rating Scale (C-SSRS) is the FDA standard for ideation and behavior measurement and the Joint Commission’s preferred screen — six screener questions, asked verbatim.
- Direct questioning does not put the idea in someone’s head. A 2014 systematic review in BJPsych Open and multiple subsequent RCTs show no induction effect; avoidance is the iatrogenic move.
- No-suicide contracts are obsolete. The Joint Commission, APA, and Suicide Prevention Resource Center moved to the Stanley-Brown safety plan years ago. New PMHNPs should never adopt the contract.
- A defensible note has four explicit elements: ideation/intent/plan/access, named static and dynamic risk factors, named protective factors, and a one-sentence clinical reasoning that links findings to disposition. “Denies SI” is a placeholder, not documentation.
On this page
“I just want to go to sleep and not wake up.” It is the sentence new PMHNPs report dreading more than any other — and the one a patient often says without warning in the last ten minutes of a visit.
The pause that follows is what the patient remembers. Half a second too long, the follow-up question lands soft, the note hedges. A 2018 JAMA Psychiatry trial of the Stanley-Brown Safety Planning Intervention found that patients who left the emergency department with a written plan in hand were 45 percent less likely to engage in suicidal behavior over the next six months and more than twice as likely to attend outpatient follow-up.
The intervention takes about 20 minutes. The script fits on one page. The bottleneck is rarely the protocol — it is the question itself.
This playbook covers the literal phrasing new PMHNPs use to ask about suicide without flinching, the six-step Stanley-Brown plan that beats usual care in randomized data, the four common missteps that erode both clinical outcomes and the chart, and the documentation language that holds up when the note is later read by a regulator, a peer reviewer, or a grieving family.
The question itself — direct, calm, specific
The Columbia-Suicide Severity Rating Scale (C-SSRS) has been the FDA’s designated standard for measuring suicidal ideation and behavior since 2012, and the Joint Commission has built it into accreditation standards since 2019. The screener version is six questions, asked verbatim. The first two establish ideation. The next four establish method, intent, plan, and behavior.
In order: Have you wished you were dead or wished you could go to sleep and not wake up? Have you actually had any thoughts of killing yourself? If yes to the second: Have you been thinking about how you might do this? Have you had these thoughts and had some intention of acting on them? Have you started to work out or worked out the details of how to kill yourself, and do you intend to carry out this plan? Have you ever done anything, started to do anything, or prepared to do anything to end your life?
Asking does not increase risk. A 2014 systematic review in BJPsych Open of 13 studies found no evidence that direct questioning induces or worsens suicidal ideation, and multiple randomized trials since have replicated the result. The clinical instinct to soften the question is not protective — it is iatrogenic. The version that gets asked as “you’re not having any thoughts of harming yourself, are you?” is structured to elicit a no.
“The single highest-leverage thing a new PMHNP can do this month is rehearse the six C-SSRS questions out loud, in their own voice, until the words come without effort. Confidence is built before the visit, not during it. The patient hears the difference in the first three seconds,” says Lindsay Hill, DNP, PMHNP-BC.
The Stanley-Brown safety plan in 20 minutes
The Stanley-Brown Safety Planning Intervention is six collaborative steps the clinician guides and the patient writes. Step 1: warning signs — the thoughts, images, mood, situations, or behaviors that precede a crisis for this patient. Step 2: internal coping strategies — things the patient can do alone to take their mind off the urge without contacting anyone. Step 3: social contacts and settings that provide distraction — people and places, not for crisis support yet. Step 4: people the patient can ask for help. Step 5: professionals and agencies — clinician on-call line, 988, local crisis line, the nearest emergency department. Step 6: lethal-means restriction.
Step 6 carries the largest single share of the evidence base. The Stanley 2018 JAMA Psychiatry cohort comparison paired the safety plan with structured follow-up phone calls in patients leaving VA emergency departments after a suicide-related visit. Compared with usual care, the intervention group had 45 percent fewer suicidal behaviors at 6 months and was more than twice as likely to attend outpatient follow-up. The treatment effect for means restriction is largely what is being measured.
The format is one page. The patient writes it in their own words. The clinician keeps a copy in the chart, and a photograph on the patient’s phone or a wallet-card printout doubles the chance the plan is consulted in a real crisis. A 2025 meta-analysis in adolescents tempered the adult signal — safety planning in pediatric populations has weaker evidence and is an active area of research.
Means restriction is the step new PMHNPs most often soft-pedal because it feels invasive to ask about firearms, medication storage, sharp objects, or alcohol access. A working script: “Reducing access to the things people use to harm themselves is the single most evidence-supported part of any safety plan. Can we walk through what you have access to right now?” Most patients answer.
What most new PMHNPs get wrong
The first misstep is the no-suicide contract. The “I promise I won’t hurt myself between now and our next visit” promise has no evidence of preventing suicide and may give the clinician a false sense of security. The Joint Commission, the American Psychiatric Association, and the Suicide Prevention Resource Center moved to collaborative safety planning years ago. New PMHNPs occasionally inherit the contract from a supervisor trained decades earlier and should replace it with the Stanley-Brown plan.
The second is reading the C-SSRS as a checklist rather than a conversation. The six questions are designed to flow. The interviewer’s eye contact, pacing, and follow-up matter as much as the literal words. The fluency comes from rehearsal, not from a print-out on the desk.
The third is skipping means restriction because it feels uncomfortable. The single piece with the strongest evidence is the piece most often omitted. A 2017 review in Annals of Internal Medicine found that means restriction counseling produced measurable behavior change — locking medications, transferring firearms to a family member, removing rope or sharp objects — in a substantial fraction of patients. Doing nothing because it feels invasive is the inverse of evidence-based care.
The fourth is documenting “denies SI” with nothing else. A note that reads “denies SI/HI/AVH, contracts for safety” with no risk factors, no protective factors, no formulation, and no safety plan is the single most common pattern flagged on retrospective chart review. It is a sentence that will not survive an audit.
Documentation that holds up
A defensible suicide risk note has four explicit elements. First, the C-SSRS responses or equivalent — what was asked, what was answered. Second, named static risk factors: prior attempts, family history of suicide, psychiatric diagnoses, chronic pain, age and sex risk profile, substance use disorder. Third, named dynamic risk factors: current symptom severity, recent losses, hopelessness, intoxication at presentation, access to lethal means, recent discharge from inpatient care. Fourth, named protective factors: social support, religious or moral objection, dependent children, ongoing treatment engagement, future-oriented thinking.
The clinical reasoning sentence is the spine. It connects the findings to the disposition: “Risk is assessed as moderate chronic with low acute exacerbation. Patient endorses passive ideation without intent or plan, has a historical attempt, denies access to firearms, lives with supportive partner, agreed to Stanley-Brown safety plan attached. Disposition: continue outpatient with safety plan; follow-up in 7 days; lethal-means counseling re: medications completed.” That sentence is what an attorney, regulator, or peer reviewer reads first. It either holds up or it does not.
Two practical templates new PMHNPs adopt early. One: a two-axis stratification — low/moderate/high acute and low/moderate/high chronic — that produces a defensible risk label rather than a single misleading number. Two: an EHR smart-phrase or macro that prepopulates the four-element scaffolding so the clinician fills in the specifics, not the structure. Both reduce the documentation tax during a busy template.
For chronic-elevated patients, plan a suicide risk inquiry at every clinical encounter and a documented re-assessment any time stressors, sleep, substance use, or medication shift meaningfully. The chart should reflect the conversation, not just the score.
Frequently asked questions
Does the C-SSRS replace clinical judgment in a PMHNP suicide risk assessment?
No. The Columbia-Suicide Severity Rating Scale is a screen that flags patients for further evaluation and standardizes documentation. A positive screen triggers a full risk formulation that integrates the C-SSRS findings with risk factors, protective factors, warning signs, lethal-means access, and the patient’s stated reasons for living. The screen is the on-ramp to the clinical decision, not the decision itself.
Is a 988 referral enough as a safety plan?
No. The 988 Suicide and Crisis Lifeline is a single component of step 4 of the Stanley-Brown safety plan and does not satisfy the other five steps — warning signs, internal coping strategies, social distractions, supportive contacts, and lethal-means restriction. A safety plan that lists only 988 is incomplete and often gets flagged in chart audits and malpractice review.
How often should a PMHNP re-assess suicide risk in a chronic-elevated outpatient?
A patient designated chronic-elevated should have a suicide risk inquiry at every clinical encounter and a documented re-assessment whenever there is a meaningful change in stressors, sleep, substance use, or medication. Visit cadence in chronic-elevated patients is typically every 2 to 4 weeks during destabilization and every 4 to 8 weeks once stable, with the safety plan reviewed at each visit. The chart should reflect the conversation, not just the score.
What does a PMHNP do when a patient declines lethal-means counseling?
Document the offer, the patient’s reason for declining, and that the conversation will be revisited at the next visit. Lethal-means counseling is a process, not a single conversation. The CALM training framework explicitly anticipates initial reluctance, especially around firearms, and recommends short, non-confrontational re-approaches. The chart entry that documents the offer is also the entry that protects the clinician.
Can a PMHNP perform a thorough suicide risk assessment over telehealth?
Yes, with structural accommodations. A telehealth risk assessment should include a video-on requirement, confirmation of the patient’s physical location and a safe-room check, a same-state collateral contact if risk is elevated, a documented plan for warm transfer to local emergency services if needed, and explicit discussion of in-home lethal means. Telehealth is not a barrier to a defensible assessment — it is a different workflow.
What is the documentation error most often flagged on suicide-related malpractice review?
Boilerplate. The phrase “denies SI/HI/AVH, contracts for safety” with no risk factors, no protective factors, no formulation, and no safety plan is the single most common pattern flagged on retrospective chart review. The defensible chart shows that the clinician asked, considered, weighed, and decided — even when the conclusion is that the patient is at low acute risk and outpatient management is appropriate.
The bottom line. The 20-minute safety plan that gets completed beats the perfect safety plan that gets postponed, and the C-SSRS asked verbatim in the clinician’s own voice beats every softened version of the question.
The next step for a new PMHNP is small and concrete. Print the Stanley-Brown safety plan template from suicidesafetyplan.com. Rehearse the six C-SSRS screener questions out loud, three times, before the next clinic. Build a four-element documentation macro into the EHR. Confidence does not arrive before the practice — it arrives because of it.
The next Psych NP Fellowship cohort is filling now.
A 12-month clinical mentorship for new and early-career PMHNPs — case consultation, prescribing rounds, risk-formulation coaching, and the documentation templates that hold up under any review.
This content is for educational purposes and does not replace individualized clinical judgment or supervision. Suicide risk assessment is a sensitive clinical topic; readers in personal crisis can reach the 988 Suicide and Crisis Lifeline by call or text in the United States.
About the author. Lindsay Hill, DNP, PMHNP-BC is the founder of the Psych NP Fellowship, a 12-month clinical mentorship program for new and early-career psychiatric nurse practitioners. She is a published contributor to Psychiatric Times, past President of the Arizona APNA Chapter, and co-founder of the Psych NP Network.
